Quarterly Period Covered: Second quarter of fiscal year 2026, ending June 26, 2026, with comparative data from Q2 2025 (ended June 27, 2025) Financial Structure: Contains consolidated financial statements including balance sheets as of June 26, 2026 and December 31, 2025, income statements for Q2 and year-to-date periods, and cash flow statements Debt Instruments Disclosed: Details multiple…

Our analysis rates this filing BEARISH. The concern level of 7.2/10 reflects a HIGH risk profile driven by multiple material headwinds. The recently completed Masimo acquisition introduces significant execution risk and goodwill impairment exposure at precisely the moment when the company faces…

Concern level: HIGH (7.2/10). Key factors: Four new high-severity risks identified with average severity 7.0/10, including major acquisition integration risk (severity 8) and goodwill impairment exposure; Overall risk trend is INCREASING with risk score of 7.8/10, indicating deteriorating risk profile; Masimo Corporation acquisition completed June 10, 2026 introduces immediate operational…

Notable risk changes: Masimo Corporation acquisition completed June 10, 2026 - transforms company's diagnostic capabilities but introduces significant integration execution risk and goodwill impairment exposure; Immediate debt maturity obligation in 2026 (A2.1 Senior Notes) requires refinancing in current market environment - creates near-term liquidity and refinancing cost risk; Acquisition-related non-recurring…

The model predicts DHR will underperform the S&P 500 by about 0.0% over 30 days (model confidence 50%). This is model analysis for research, not investment advice.